Skip to main content

Table 1 Laboratory findings of the patient.

From: Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis

  2001 2006   
During inflammatory
calcinosis
Before thalidomide
(inacitive phase)
3 months 12 months
WBC (μL) 27,300 7,100 6,400 5,200
Hb (g/dL) 11.6 11.3 9.5 12.7
Platelets (×104/μL) 24.7 24.6 35.7 35.7
ESR (mm/h) 27 17 3 4
FDP-E (ng/mL) 225 237 95 85
AST (U/L) 20    
ALT (U/L) 7    
LDH (U/L) 271    
CRP (mg/dL) 21.0 0.2 0.1 0.4
Triglycerides (mg/dL) nd 251 74 93
Total cholesterol (mg/dL) nd 121 145 156
IgG (mg/dL) nd 2,056 813 916
  1. The levels of FDP-E, IgG, and triglycerides were all elevated before thalidomide gradually reduced them to the normal range.